Results 181 to 190 of about 1,656,609 (285)

The Insulin‐Like Growth Factor System and Neurological Complications in Diabetes

, 2003
Anders A. F. Sima, Zhenguo Li, Wei‐xian Zhang   +2 more
openalex   +1 more source

RAB39B Related Parkinsonism in an Italian Family: A Unique Use of Advanced Therapies

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Parkinson's disease (PD) is a neurodegenerative disorder that may sometimes be caused by deleterious genetic variants. Among them, RAB39B polymorphisms are known as rare causes of early‐onset PD associated with intellectual disability (Waisman's syndrome).
Caterina Del Regno, Giovanni Ermanis, Christian Lettieri, Andrea Bernardini, Gaia Pellitteri, Enrico Belgrado, Elena Betto, Gian Luigi Gigli, David De Monte, Marco Domenico Scanni, Marco Mucchiut, Giuseppe Damante, Mariarosaria Valente, Francesco Janes   +13 more
wiley   +1 more source

Expanding Evidence of Leptomeningeal Involvement in MOGAD and Its Relevance to Its Pathophysiology. [PDF]

Neurol Neuroimmunol Neuroinflamm
Cacciaguerra L, Flanagan EP.
europepmc   +1 more source

Effectiveness of Caregivers’ Yoga Module on Psychological Distress and Mental Well-Being among Caregivers of Patients Admitted to Neurological Rehabilitation Wards of a Tertiary Care Institute, Bengaluru, Karnataka, India

, 2019
Sailaxmi Gandhi, Vinaya Kumar Palled, Maya Sahu, Aarti Jagannathan, Meeka Khanna, Amrutha Jose   +5 more
openalex   +1 more source

Neurological Manifestations and Its Outcome Due to Covid-19 Disease: An Observational Study

, 2022
Khalil Ahmed, Muhammad Khan Malik, Nasar Iqbal Ranjha, Azeem   +3 more
openalex   +2 more sources

Correction to “The Importance of Verifying the Novelty of a Finding and the Value of Combining Results”

Annals of Clinical and Translational Neurology, EarlyView.
wiley   +1 more source

Amyotrophic Lateral Sclerosis Prevalence Projection in 2040: A Less Rare Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To project ALS prevalence across multiple countries through 2040, accounting for both population aging and increased survival. Methods Data from the Piemonte and Valle d'Aosta ALS register (PARALS) was used to estimate the trends in incidence and prevalence from 2005 to 2019. Survival trends over this period were also assessed.
Rosario Vasta, Stefano Callegaro, Antonio Canosa, Umberto Manera, Maurizio Grassano, Francesca Palumbo, Sara Cabras, Enrico Matteoni, Francesca Di Pede, Filippo De Mattei, Salvatore Tafaro, Neil M. Thakur, Ryan Grosenick, Fabiola De Marchi, Letizia Mazzini, Cristina Moglia, Andrea Calvo, Kuldip D. Dave, Adriano Chiò   +18 more
wiley   +1 more source

Global & Community Health: What Did the COVID-19 Pandemic Teach Us About Neurologic Surveillance Approaches, and How Should We Be Better Prepared? [PDF]

Neurology
Matthews R, Ellul MA, McKeever S, Pollack T, Houlihan C, Thakur KT, Hsiang-Yi Chou S, Frontera JA, Saylor DR, Chomba M, Moro E, Ray STJ, Semple MG, Smith CJ, Turner MR, Bullmore E, Carson A, Buchan I, Breen G, Solomon T, Nicholson TR, Pett S, Thomas RH, Michael BD.   +23 more
europepmc   +1 more source

Time-course full profiling of circulating miRNAs in neurologically deceased organ donors: a proof of concept study to understand the onset of the cytokine storm

, 2022
Andrée‐Anne Clément, Daphnée Lamarche, Marie-Hélène Masse, Cécilia Légaré, Lee‐Hwa Tai, Laurence Fleury Deland, Marie‐Claude Battista, Luigi Bouchard, Frédérick D’Aragon   +8 more
openalex   +2 more sources

Plasma Proteomic Signatures for Alzheimer's Disease: Comparable Accuracy to ATN Biomarkers and Cross‐Platform Validation

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background There is growing recognition of the potential of plasma proteomics for Alzheimer's Disease (AD) risk assessment and disease characterization. However, differences between proteomics platforms introduce uncertainties regarding cross‐platform applicability.
Manyue Hu, Oliver Robinson, Christina M. Lill, Anna Matton, Raquel Puerta, Pilar Sanz, Merce Boada, Agustín Ruiz, Lefkos Middleton, for the Alzheimer's Disease Neuroimaging Initiative   +9 more
wiley   +1 more source